This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Globavir Biosciences, Inc.. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Usha Nagavarapu: Innovator in Heterocyclic Compounds
Introduction
Usha Nagavarapu is a prominent inventor based in San Jose, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel heterocyclic compounds. With a total of 2 patents to her name, her work focuses on addressing critical health challenges through innovative chemical solutions.
Latest Patents
Usha's latest patents include groundbreaking research on heterocyclic compounds and their applications. These patents disclose novel heterocyclic compounds, their salts, and pharmaceutical compositions that comprise such compounds. The inventions aim to modulate protein-protein interactions and provide therapeutic solutions for diseases resulting from aberrant protein-protein interactions. This research holds promise for advancing treatment options in various medical fields.
Career Highlights
Usha Nagavarapu is currently associated with Globavir Biosciences, Inc., where she continues to push the boundaries of innovation in her field. Her expertise in heterocyclic compounds has positioned her as a valuable asset in the pharmaceutical industry. Usha's dedication to research and development has led to significant advancements in drug formulation and therapeutic applications.
Collaborations
Usha collaborates with talented professionals in her field, including her coworker Chenera Balan. Together, they work on innovative projects that aim to enhance the efficacy of pharmaceutical compounds and improve patient outcomes.
Conclusion
Usha Nagavarapu's contributions to the field of heterocyclic compounds exemplify her commitment to innovation and excellence in pharmaceutical research. Her work not only advances scientific knowledge but also has the potential to improve healthcare solutions for many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile